From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria.
about
RRx-001: a systemically non-toxic M2-to-M1 macrophage stimulating and prosensitizing agent in Phase II clinical trials.Glutathione-deficient Plasmodium berghei parasites exhibit growth delay and nuclear DNA damage.Epigenetic effects of RRx-001: a possible unifying mechanism of anticancer activity.The macrophage stimulating anti-cancer agent, RRx-001, protects against ischemia-reperfusion injury.Rat red blood cell storage lesions in various additive solutions.A look inside the mechanistic black box: Are red blood cells the critical effectors of RRx-001 cytotoxicity?
P2860
From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
From METS to malaria: RRx-001, ...... activity in cerebral malaria.
@ast
From METS to malaria: RRx-001, ...... activity in cerebral malaria.
@en
type
label
From METS to malaria: RRx-001, ...... activity in cerebral malaria.
@ast
From METS to malaria: RRx-001, ...... activity in cerebral malaria.
@en
prefLabel
From METS to malaria: RRx-001, ...... activity in cerebral malaria.
@ast
From METS to malaria: RRx-001, ...... activity in cerebral malaria.
@en
P2093
P2860
P1433
P1476
From METS to malaria: RRx-001, ...... activity in cerebral malaria.
@en
P2093
Frans A Kuypers
Jan Scicinski
Leonardo J M Carvalho
Ozlem Yalcin
P2860
P2888
P356
10.1186/S12936-015-0720-5
P577
2015-05-28T00:00:00Z
P6179
1036630008